Fumonisin B4

Fumonisin B4 is a type of mycotoxin produced by certain species of the fungus Fusarium, which includes strains such as Fusarium verticillioides and Fusarium proliferatum. These fungi are commonly found on maize (corn) and other cereals in the field or during storage when conditions favor their growth, such as high moisture content. Fumonisins are a family of toxins, among which Fumonisin B1, Fumonisin B2, and Fumonisin B3 are the most studied due to their prevalence and potent toxicity. Fumonisin B4, while less studied, contributes to the overall toxicological profile of contaminated grains and foods.
Structure and Biosynthesis[edit]
Fumonisin B4 shares a similar structure with other fumonisins, characterized by a long-chain hydrocarbon backbone and tricarballylic acid side chains. The biosynthesis of fumonisins involves a series of enzymatic steps catalyzed by the fumonisin biosynthetic pathway encoded by a cluster of genes in Fusarium species. This pathway is complex, involving the formation of the backbone and the addition of side chains, which results in the production of various fumonisin isoforms.
Toxicity and Health Effects[edit]
The toxicity of fumonisin B4 is generally considered to be lower than that of fumonisin B1, the most potent and studied of the fumonisins. However, fumonisin B4 can contribute to the overall toxic effects of fumonisin-contaminated food and feed. Fumonisins disrupt lipid metabolism by inhibiting the enzyme ceramide synthase, leading to alterations in sphingolipid metabolism. This disruption can result in cell death and organ toxicity, particularly in the liver and kidneys. The specific health effects of fumonisin B4 on humans and animals are less documented compared to other fumonisins, but the potential for harm suggests a need for further research.
Detection and Control[edit]
Detection of fumonisin B4 in food and feed products is crucial for ensuring safety and compliance with regulatory standards. Various analytical methods, including chromatography and mass spectrometry, are used to quantify fumonisin levels. Control measures to reduce fumonisin contamination include proper agricultural practices, such as crop rotation and timely harvesting, and post-harvest strategies like drying and proper storage to prevent fungal growth.
Regulation[edit]
Regulatory agencies worldwide have established limits for fumonisin levels in food and feed to protect human and animal health. These limits typically focus on fumonisin B1, B2, and B3, given their prevalence and known toxicity. The inclusion of fumonisin B4 in regulatory guidelines varies by region and is subject to change as new research emerges on its toxicity and occurrence.
Conclusion[edit]
While fumonisin B4 is less studied than other fumonisins, its presence in contaminated food and feed contributes to the risk posed by these mycotoxins. Ongoing research is essential to fully understand the health impacts of fumonisin B4 and to refine detection and control methods. Ensuring the safety of food and feed requires a comprehensive approach to managing fumonisin contamination, including monitoring for all relevant fumonisin isoforms.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
